Additionally, S&P raised the long-term rating on the finance authority’s series 2009B and 2009D bonds to “AAA” from “AA+,” and affirmed the “AA+/A-1” rating on its series 2009C bonds.
“The rating action reflects our view of Parkview’s strategic direction, which sustains the leading market position that has grown over the years,” said S&P Global Ratings credit analyst Brian Williamson.
The outlook is stable, reflecting S&P’s expectation that Parkview will invest capital and remain a leader in the industry.
More articles on healthcare finance:
4 of 37 provider-sponsored health plans profitable in 2015
Illinois ordered to increase Medicaid funding to providers during budget impasse
Federal judge to decide whether Illinois must expedite $2B in Medicaid payments owed to providers in budget stalemate
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
